Skip to main content

Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy

  • Book
  • © 2016

Overview

  • Gives the latest research on specific defects in T cell trafficking, which hinder the success of cancer immunotherapy
  • Provides the basic priniciples to T cell migration during efficient immune responses
  • Explores therapeutic interventions to promote T cell migration into tumors
  • Includes supplementary material: sn.pub/extras

Part of the book series: Resistance to Targeted Anti-Cancer Therapeutics (RTACT, volume 9)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (8 chapters)

Keywords

About this book

This volume focuses on recent advances in understanding T cells as key players in antitumor immune responses, and as a result T cell-based immunotherapy is starting to transform the treatment of advanced cancers. However, despite recent successes, many patients with cancer fail to respond to these treatments. Defective migration of T cells into and within tumors is considered as an important resistance mechanism to cancer immunotherapy.The volume includes three sections. The first section covers general knowledge about T cell trafficking during a normal immune response but also during tumor development. The second section provides an in-depth description of the different obstacles that prevent T cells from migrating and contacting tumor cells. The third section explores therapeutic strategies to improve trafficking of T cells into tumors and, thus, to enhance the effectiveness of cancer immunotherapy.

Editors and Affiliations

  • Institut Cochin INSERM, Université Paris Descartes, Paris, France

    Emmanuel Donnadieu

About the editor

Emmanuel Donnadieu, Ph.D, is a researcher and team leader of the 'Dynamics of T cell Interactions' group at the Cochin Institute. His recent research include breakthroughs in newly developed methods for following the migration and activation patterns of lymphocytes and other immune cells within tumors.

Bibliographic Information

  • Book Title: Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy

  • Editors: Emmanuel Donnadieu

  • Series Title: Resistance to Targeted Anti-Cancer Therapeutics

  • DOI: https://doi.org/10.1007/978-3-319-42223-7

  • Publisher: Springer Cham

  • eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)

  • Copyright Information: Springer International Publishing Switzerland 2016

  • Hardcover ISBN: 978-3-319-42221-3Published: 06 September 2016

  • Softcover ISBN: 978-3-319-82528-1Published: 22 April 2018

  • eBook ISBN: 978-3-319-42223-7Published: 30 August 2016

  • Series ISSN: 2196-5501

  • Series E-ISSN: 2196-551X

  • Edition Number: 1

  • Number of Pages: VIII, 199

  • Number of Illustrations: 8 b/w illustrations, 19 illustrations in colour

  • Topics: Cancer Research, Immunology, Molecular Medicine

Publish with us